drugset / Trial / NCT01144897

PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy

NCT01144897 ↗

Phase 1 Completed 5 enrolled Daniel Vaena
NaSingle-groupOpen-labelDiagnostic

Summary

One purpose of this research study is to examine if a special type of imaging test, a positron emission tomography (PET) scan using the radioactive material \[C-11\] acetate, will be helpful in detecting prostate cancer lesions in subjects with castrate-resistant prostate cancer (CRPC). This PET scan will be combined with a computed tomography (CT) scan taken during the same imaging session. The other purpose of the PET-CT scan using \[C-11\] acetate (PET Acetate Scan) is to assist in identifying who is responding to the treatment (docetaxel chemotherapy).

Timeline

Start
2010-05
Primary completion
2011-11
Completion
2018-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbon-11 labeled Acetate Diagnostic / imaging agent — —